RIT: RITONAVIR
RIT is a Ligand Of Interest in 3PRS designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3PRS_RIT_A_1001 | 93% | 40% | 0.071 | 0.967 | 0.99 | 1.32 | 2 | 7 | 3 | 0 | 100% | 1 |
| 3NXU_RIT_A_600 | 55% | 1% | 0.144 | 0.913 | 5.85 | 3.07 | 34 | 25 | 8 | 0 | 100% | 1 |
| 7VE0_RIT_A_401 | 51% | 39% | 0.137 | 0.89 | 0.95 | 1.42 | 2 | 7 | 0 | 0 | 100% | 1 |
| 4NJV_RIT_A_500 | 34% | 11% | 0.187 | 0.869 | 2.25 | 1.9 | 11 | 13 | 6 | 0 | 100% | 1 |
| 1SH9_RIT_B_301 | 21% | 7% | 0.26 | 0.871 | 2.16 | 2.62 | 16 | 13 | 13 | 0 | 100% | 0.6 |
| 3TNE_RIT_A_401 | 18% | 23% | 0.237 | 0.822 | 1.25 | 1.92 | 2 | 14 | 13 | 0 | 100% | 1 |
